Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


Published on .

IN THE FACE OF SKEPTICISM: Rubel & Schwab Communications Inc., Toronto, shows us how strongly Pharmacia & Upjohn's customers feel for Provera, a hormone replacement therapy relieving menopausal symptoms. The copy describes the price-point advantage and says, "Suddenly, it's easy to see why Provera remains the most widely prescribed progestin."
Most Popular
In this article: